10 – 13 November 2024

Join Avance Clinical at the CNS Summit 2024

Join Avance Clinical at the  CNS Summit 2024

Join Avance Clinical at the CNS Summit 2024

Avance Clinical is thrilled to announce our participation in the CNS Summit 2024, taking place from November 10 – 13, 2024, in Boston, MA. The CNS Summit is a premier event dedicated to advancing clinical development and technology innovation in the Central Nervous System (CNS) therapeutic area. The Summit brings together a curated group of top decision makers from pharma, biotech, CROs, investigator sites, patient advocacy groups, investors and other stakeholders.

Engage with Our Specialists

We are excited to have three of our top specialists from the United States attending the CNS Summit, ready to engage in partnering meetings and discussions about the latest advancements in CNS clinical trials.

Clint Henry

Clint Henry

Director of Business Development

Clint Henry's LinkedIn Profile

Read more

Kelly Brown

Kelly Brown

Project Director I

Kelly Brown's LinkedIn Profile

 

Why Meet with Us?

The CNS Summit offers a unique opportunity to explore how Avance Clinical can support your CNS drug development programs. Our team is well-versed in the challenges and opportunities within the CNS therapeutic area, and we are eager to discuss how our comprehensive services can help accelerate your clinical trials. From early-phase trials to global regulatory strategies, Avance Clinical is your trusted partner in CNS drug development.

Schedule a Partnering Meeting

Don’t miss the opportunity to meet with Kevin Leach, Clint Henry, and Kelly Brown during the CNS Summit. Whether you are exploring new CNS therapies or looking to optimize your clinical trial processes, our experts are here to provide insights and solutions tailored to your needs.

To arrange a partnering meeting, please contact us.

We look forward to seeing you in Boston and exploring how we can collaborate to advance your CNS therapeutic programs!

Find out more

Discover how CROs with in-house regulatory affairs deliver 30% savings, halve timelines, and cut risk for biotechs in the Frost & Sullivan report here.

Find out more about our GlobalReady program for biotechs looking to globalize their drug development strategy – watch the video now.

Book a meeting with us

Book a meeting
Terms and conditions

Related Events